Stock PAREXEL INTERNATIONAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News PAREXEL International Corporation

Equities

US6994621075

Biotechnology & Medical Research

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships
19-06-23
 BU
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry
17-12-12
 BU
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry
17-11-15
 BU
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International
17-09-29
 BU
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management
17-09-18
 BU
PAREXEL International : Medical Research Stock Performance Review -- Exact Sciences, DexCom, and PAREXEL
17-09-13
 PR
PAREXEL International : Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
17-09-06
 BU
PAREXEL International : Reports Fourth Quarter and Fiscal Year 2017 Results
17-08-28
 BU
PAREXEL International : Announces Date of Fourth Quarter and Fiscal Year 2017 Earnings Release
17-08-21
 BU
PAREXEL International : and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
17-08-21
 BU
Monteverde & Associates PC Announces An Investigation Of PAREXEL International Corporation - PRXL
17-08-15
 PR
PAREXEL International Corporation : Announces $720 Million Senior Notes Offering by West Street Merger Sub, Inc.
17-08-07
 BU
PAREXEL International : Two PAREXEL Executives Named to 2017 PharmaVOICE 100
17-08-01
 BU
PAREXEL International : Receives CEO Cancer Gold Standard Re-Accreditation
17-07-11
 BU
PAREXEL International : Named to the Forbes America’s Best Employers List for Second Consecutive Year
17-06-26
 BU
The Law Offices of Vincent Wong : Notifies Investors of an Investigation of PAREXEL International Corporation in Connection with the Sale of the Company to Pamplona Capital Management, LLP
17-06-22
 BU
Brower Piven Commences an Investigation into the Proposed Sale of PAREXEL International Corporation and Encourages Investors to Contact the Firm for Additional Information
17-06-21
 BU
PAREXEL INTERNATIONAL CORPORATION Former SEC Attorney Willie Briscoe Investigates Sale to Pamplona Capital Management, LLP
17-06-21
 BU
Levi & Korsinsky, LLP Remind Investors of an Investigation Concerning Whether the Sale of PAREXEL International Corporation to Pamplona Capital Management, LLP Is Fair to Shareholders
17-06-21
 BU
Harwood Feffer LLP : Announces Investigation of PAREXEL International Corporation
17-06-20
 PR
PAREXEL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PAREXEL International Corporation
17-06-20
 PR
PAREXEL INTERNATIONAL CORPORATION Rigrodsky & Long, P.A. Announces Investigation Of Buyout
17-06-20
 BU
Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of PAREXEL International Corporation to Pamplona Capital Management, LLP is Fair to Shareholders
17-06-20
 BU
PAREXEL ALERT: J&W Investigates Proposed Sale of PAREXEL International; Is $88.10 a Fair Price?
17-06-20
 PR
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion
17-06-20
 RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News PAREXEL International Corporation